Frontiers launches a new open-access medical journal: Frontiers in Cardiovascular Medicine

Swiss open-access publisher Frontiers, part of the Nature Publishing Group family, is pleased to announce the launch of Frontiers in Cardiovascular Medicine, a new open-access medical journal.

Frontiers in Cardiovascular Medicine will publish peer-reviewed articles on the diagnosis, treatment, and pathogenesis of cardiovascular disease that help to advance medical education and to improve clinical practice and patient care.

Frontiers in Cardiovascular Medicine provides unrestricted access to the most current and clinically relevant information to clinicians, health professionals, and medical educators, reaching every country in the world. I am confident that the journal will become a key knowledge resource for cardiovascular medicine,“ says Chief Editor Matthias Barton, MD, of the University of Zürich in Switzerland. “With each discipline led by renowned clinician-scientists as Chief Editors with their own editorial board of experts, we can ensure independent, high-quality and fast review of every manuscript received,” adds Barton.

Frontiers in Cardiovascular Medicine will provide unrestricted and global online access to all articles, published under the Creative Commons Attribution (CC-BY) license. The Frontiers Interactive Peer Review will enable authors, reviewers and editors to directly and collaboratively engage in a Review Forum, ensuring a rigorous and objective review, and fast publication. Reviewer names are disclosed on articles to enhance transparency. Frontiers advanced article impact metrics track the reach and impact of articles, and the community can engage in post-publication review.

Frontiers in Cardiovascular Medicine is now open for submissions for the following sections:

Clinical Arrhythmology Cardiopulmonary Medicine
Manlio F. Marquez, MD, FACC Antonio M. Esquinas, MD, PhD, FCCP
Instituto Nacional de Cardiologia, Mexico Hospital General Universitario Morales Meseguer, Spain
Cardiovascular Epidemiology Cardiovascular Genetics
Erik Ingelsson, MD, PhD Silke R. Sperling, MD, FESC
Uppsala University, Sweden Charité University Hospital, Berlin, Germany
Cardiovascular Therapeutics Molecular Cardiology
Ian B, Wilkinson, BM, DM, FRCP Edward J. Lesnefsky, MD, FACC, FAHA
University of Cambridge, UK Virginia Commonwealth University, USA
Coronary Cardiology Lipidology and Metabolism
David Erlinge, MD, PhD, FACC, FESC Carmine Cardillo, MD
Lund University, Sweden Catholic University Medical School, Italy
John Pernow, MD, PhD, FESC Claudio Cortese, MD
Karolinska Institutet, Stockholm, Sweden University of Rome Tor Vergata, Italy
Matthias Barton, MD, FAHA
University of Zurich, Switzerland
General Cardiology Heart Failure
Elizabeth O. Ofili, MD, MPH, FACC Howard J.Eisen, MD, FACC, FAHA, FACP
Moorehouse School of Medicine, Atlanta,
Hahnemann University Hospital, Philadelphia, USA
Hypertension  Thrombosis 
Gian Paolo Rossi, MD, FACC, FAHA Irene M. Lang, MD, FESC
University of Padova, Italy University Hospital Vienna, Austria
Regenerative Cardiology Vascular Medicine
Duncan J. Stewart, MD, FACC, FRCPC Marc Husmann, MD
Ottawa Hospital Research Institute, Canada University Hospital Zurich, Switzerland
Darryl R. Davis, MD Matthias Barton, MD, FAHA
University of Ottawa Heart Institute, Canada University of Zurich, Switzerland
Cardiovascular Imaging
Leonard Kritharides, MBBS, PhD, FRACP, FAHA
University of Sydney, Australia